CryoPort Inc (NASDAQ:CYRX) Receives $23.25 Consensus Price Target from Analysts

CryoPort Inc (NASDAQ:CYRX) has earned an average rating of “Buy” from the seven analysts that are presently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1-year target price among brokers that have covered the stock in the last year is $23.25.

Several research analysts have recently issued reports on CYRX shares. ValuEngine cut CryoPort from a “buy” rating to a “hold” rating in a research note on Tuesday, December 3rd. Stephens initiated coverage on CryoPort in a report on Tuesday, January 7th. They issued an “overweight” rating and a $21.00 price objective on the stock. BidaskClub raised CryoPort from a “sell” rating to a “hold” rating in a report on Friday, March 20th. Janney Montgomery Scott reissued a “buy” rating and issued a price objective on shares of CryoPort in a report on Friday, March 6th. Finally, B. Riley dropped their price objective on CryoPort from $26.00 to $24.00 and set a “buy” rating on the stock in a report on Thursday, February 13th.

CryoPort stock traded up $0.36 during midday trading on Monday, reaching $15.89. The company’s stock had a trading volume of 7,359 shares, compared to its average volume of 496,145. The stock’s 50-day simple moving average is $17.15 and its 200-day simple moving average is $16.42. The company has a debt-to-equity ratio of 0.03, a current ratio of 18.86 and a quick ratio of 18.77. CryoPort has a 52-week low of $12.35 and a 52-week high of $25.02. The stock has a market capitalization of $595.62 million, a P/E ratio of -29.11 and a beta of 0.81.

CryoPort (NASDAQ:CYRX) last released its quarterly earnings results on Thursday, March 5th. The consumer goods maker reported ($0.03) EPS for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.04. CryoPort had a negative return on equity of 19.08% and a negative net margin of 54.01%. The company had revenue of $9.20 million during the quarter, compared to analysts’ expectations of $9.20 million. During the same period last year, the business posted ($0.08) earnings per share. The firm’s revenue was up 61.4% compared to the same quarter last year. As a group, equities research analysts expect that CryoPort will post -0.19 earnings per share for the current fiscal year.

A number of institutional investors and hedge funds have recently modified their holdings of CYRX. Chevy Chase Trust Holdings Inc. raised its position in CryoPort by 174.4% in the third quarter. Chevy Chase Trust Holdings Inc. now owns 1,650,514 shares of the consumer goods maker’s stock valued at $26,994,000 after purchasing an additional 1,049,090 shares during the period. Janus Henderson Group PLC purchased a new stake in shares of CryoPort in the 4th quarter valued at $8,592,000. Victory Capital Management Inc. raised its holdings in shares of CryoPort by 20.3% in the 4th quarter. Victory Capital Management Inc. now owns 2,348,908 shares of the consumer goods maker’s stock valued at $38,663,000 after buying an additional 396,281 shares during the period. State Street Corp raised its holdings in shares of CryoPort by 41.3% in the 3rd quarter. State Street Corp now owns 934,287 shares of the consumer goods maker’s stock valued at $15,280,000 after buying an additional 273,280 shares during the period. Finally, Handelsbanken Fonder AB raised its holdings in shares of CryoPort by 133.3% in the 4th quarter. Handelsbanken Fonder AB now owns 420,000 shares of the consumer goods maker’s stock valued at $6,913,000 after buying an additional 240,000 shares during the period. 77.52% of the stock is currently owned by institutional investors.

About CryoPort

CryoPort, Inc engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers.

Further Reading: What does a bar chart display?

Analyst Recommendations for CryoPort (NASDAQ:CYRX)

Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.